Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 924

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 3
Chunk 924
---
 79,269 Research and development134,922 187,170 193,000 Sales and marketing87,244 79,287 84,465 General and administrative87,773 90,531 76,389 Impairment charges184,500 — — Merger-related expenses— 9,042 — Change in fair value of contingent consideration(850)15,060 2,377 Amortization of acquired intangible assets18,006 6,157 — Loss on extinguishment of debt— 2,033 — Gain on debt restructuring(154,407)— — Other income (expense), net10,371 18,341 (7,052)Income tax provision (benefit)316 (11,424)— Consolidated net loss(309,851)(306,735)(314,248)A summary of our revenue by geographic location is as follows:Years Ended December 31,(in thousands)202420232022Americas (1)$78,711 $105,410 $69,561 Europe, Middle East, and Africa34,594 40,658 22,598 Asia-Pacific40,709 54,453 36,145 Total $154,014 $200,521 $128,304 (1)     Includes United States revenue of $75.3 million, $100.5 million, and $66.8 million for the years ended December 31, 2024, 2023, and 2022, respectively.A summary of our revenue by category is as follows: Years Ended December 31,(in thousands)202420232022Instrument revenue$65,776 $120,451 $48,719 Consumable revenue70,373 63,421 59,980 Product revenue136,149 183,872 108,699 Service and other revenue17,865 16,649 19,605 Total revenue$154,014 $200,521 $128,304 

Fiscal 2024 Form 10-K124

NOTE 12.  SUBSEQUENT EVENTSOn March 7, 2025, we entered into an amendment to our existing lease for our corporate headquarters, research and development facilities, and manufacturing and distribution centers in Menlo Park, California. The lease amendment extends the term from the prior expiration on October 31,